CH0432492467
© BusinessWire
20.01.2026
ALC
LISTED
NYSE
Alcon Completes $750 Million Share Repurchase Program
News Preview
Alcon Inc., the global leader in eye care dedicated to helping people see brilliantly, today announced the completion of its $750 million share repurchase program, which commenced on April 1, 2025.
In aggregate, 9,301,877 registered shares were acquired on the SIX Swiss Exchange, representing 1.9% of the current share capital of Alcon Inc. The t...
Themefolio
Profiler
Peergroup
© BusinessWire
07.01.2026
ALC
LISTED
NYSE
Alcon Terminates Agreement to Acquire STAAR Surgical
News Preview
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today terminated its definitive merger agreement with STAAR Surgical Company (NASDAQ: STAA) announced on August 5, 2025.
“Throughout this process we remained disciplined with our views on price and risk. Moving forward, our refractive strategy is un...
Themefolio
Profiler
Peergroup
© BusinessWire
30.12.2025
ALC
LISTED
NYSE
Alcon to Present at 2026 Annual J.P. Morgan Healthcare Conference
News Preview
Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 a.m. PST.
A live webcast of the conference will be available at investor.alcon.com/news-and-events/events-and-presentations.
About Alcon
Alcon helps people see brilliantly. As the global leader in eye care...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
17.12.2025
ALC
LISTED
NYSE
Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc.
News Preview
Expresses Disappointment in the Board's and Management's Continued Pursuit of Ill-advised DealCHARLOTTE, N.C., Dec. 17, 2025 /PRNewswire/ -- Defender Capital ("Defender" or "we"), a long-term shareholder of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) owning approximately 1.5% of the Company's outstanding common stock, today is...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
23.01.2026
© BusinessWire
09.12.2025
ALC
LISTED
NYSE
Alcon Announces Amended Merger Agreement with STAAR Surgical
News Preview
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that it has entered into an amended merger agreement for the acquisition of STAAR Surgical Company (NASDAQ: STAA, “STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision corr...
Themefolio
Profiler
Peergroup
© BusinessWire
11.11.2025
ALC
LISTED
NYSE
Alcon Delivers Solid Third-Quarter 2025 Results with Accelerated Growth in Equipment and Ocular Health; Unity VCS Momentum Builds
News Preview
Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three and nine month periods ending September 30, 2025. For the third quarter of 2025, sales were $2.6 billion, up 6% on a reported basis and up 5% on a constant currency basis1, as compared to the same quarter of the previous year. Alcon reported diluted e...
Themefolio
Profiler
Peergroup
© BusinessWire
04.11.2025
ALC
LISTED
NYSE
Alcon Releases Investor Discussion Materials Reinforcing Certain Value of Merger Proposal for STAAR Stockholders
News Preview
Alcon (SIX/NYSE: ALC), the global leader in eye care, today announced that it has filed an investor presentation in support of the proposed acquisition of STAAR Surgical Company (NASDAQ: STAA) with the U.S. Securities and Exchange Commission (SEC). Alcon plans to initiate outreach to STAAR stockholders and the presentation highlights key considera...
Themefolio
Profiler
Peergroup
© PR Newswire
07.10.2025
ALC
LISTED
NYSE
Defender Capital Opposes STAAR Surgical's Proposed Sale to Alcon
News Preview
CHARLOTTE, N.C., Oct. 7, 2025 /PRNewswire/ -- Defender Capital ("Defender" or "we"), a long-term shareholder of STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) owning approximately 1.5% of the Company's outstanding common stock, today issued the following statement outlining its opposition of the...
Themefolio
Profiler
Peergroup
© BusinessWire
16.09.2025
ALC
LISTED
NYSE
Alcon Announces New Time and Motion Study Results Supporting Superior Efficiency* for Cataract and Vitreoretinal Surgery with UNITY VCS
News Preview
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, announced results from time and motion studies demonstrating superior efficiency* with UNITY® Vitreoretinal Cataract System (VCS) for vitreoretinal and cataract surgery compared to CONSTELLATION® Vision System and CENTURION® Vision System with ACTIVE...
Themefolio
Profiler
Peergroup
© BusinessWire
08.09.2025
ALC
LISTED
NYSE
Alcon Launches Groundbreaking Innovations and Highlights New Study Findings at ESCRS 2025
News Preview
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, will present compelling scientific data at the 43rd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) in Copenhagen, Denmark from 12-15 September. During the meeting, Alcon will showcase groundbreaking cataract, refractive a...
Themefolio
Profiler
Peergroup
© BusinessWire
26.08.2025
ALC
LISTED
NYSE
Alcon to Present at 2025 Baird Global Healthcare Conference
News Preview
Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2025 Baird Global Healthcare Conference on Tuesday, September 9, 2025, at 9:05 a.m. ET.
A live webcast of the conference will be available at investor.alcon.com/news-and-events/events-and-presentations.
About Alcon
Alcon helps people see brilliantly. As the global leader in eye car...
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2025
ALC
LISTED
NYSE
Alcon Reports Second-Quarter 2025 Results, Launched Tryptyr and Announced Acquisition of STAAR Surgical
News Preview
Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three and six month periods ending June 30, 2025. For the second quarter of 2025, sales were $2.6 billion, up 4% on a reported basis and up 3% on a constant currency basis1, as compared to the same quarter of the previous year. Alcon reported diluted earnin...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
19.08.2025
ALC
LISTED
NYSE
Alcon Underscores Benefits of Its IOLs and Cataract Surgical Equipment at APACRS
News Preview
Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced a strong presence at the 37th Asia-Pacific Association of Cataract and Refractive Surgeons (APACRS) Annual Meeting. APACRS will be held at Mahatma Mandir Convention and Exhibition Centre (MMCEC) in Ahmedabad, India from August 21-23, 2025. The company...
Themefolio
Profiler
Peergroup
© PR Newswire
22.07.2025
ALC
LISTED
NYSE
Artificial Intelligence Influence in Ophthalmology Industry Projected to Create a Billion Dollar Revenue Opportunity
News Preview
MarketNewsUpdates News Commentary
NEW YORK, July 22, 2025 /PRNewswire/ -- According to a report from Research And Markets, the AI in Ophthalmology Market was valued at USD 209.23 million in 2024, and is projected to reach USD 1.36 billion by 2030, rising at a CAGR of 36.79%. The rising prevalence of eye diseases, advancements in imaging technolog...
Themefolio
Profiler
Peergroup
© PR Newswire
22.07.2025
ALC
LISTED
NYSE
Artificial Intelligence Influence in Ophthalmology Industry Projected to Create a Billion Dollar Revenue Opportunity
News Preview
MarketNewsUpdates News Commentary
NEW YORK, July 22, 2025 /CNW/ -- According to a report from Research And Markets, the AI in Ophthalmology Market was valued at USD 209.23 million in 2024, and is projected to reach USD 1.36 billion by 2030, rising at a CAGR of 36.79%. The rising prevalence of eye diseases, advancements in imaging technology, and...
Themefolio
Profiler
Peergroup
© PR Newswire
22.07.2025
ALC
LISTED
NYSE
Artificial Intelligence Influence in Ophthalmology Industry Projected to Create a Billion Dollar Revenue Opportunity
News Preview
MarketNewsUpdates News Commentary
NEW YORK, July 22, 2025 /PRNewswire/ -- According to a report from Research And Markets, the AI in Ophthalmology Market was valued at USD 209.23 million in 2024, and is projected to reach USD 1.36 billion by 2030, rising at a CAGR of 36.79%. The rising prevalence of eye diseases, advancements in imaging technolog...
Themefolio
Profiler
Peergroup
© BusinessWire
08.07.2025
ALC
LISTED
NYSE
Alcon’s Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval
News Preview
Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that UNITY® Vitreoretinal Cataract System (VCS) has received Health Canada approval. This innovation is the first to be introduced from Alcon’s highly anticipated Unity portfolio.
This press release features multimedia. View the full release here: ht...
Themefolio
Profiler
Peergroup
© BusinessWire
07.07.2025
ALC
LISTED
NYSE
Alcon to Acquire LumiThera and Its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD)
News Preview
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced its intention to acquire LumiThera, Inc., a leader in light-based innovations for ophthalmology, and its PBM device for the treatment of early and intermediate dry AMD.1 LumiThera’s PBM is the only device that has demonstrated meaningf...
Themefolio
Profiler
Peergroup
© BusinessWire
26.06.2025
ALC
LISTED
NYSE
Alcon Canada Earns Global Recognition as a Top Employer
News Preview
Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that Alcon Canada has been certified as a Top Employer in Canada by the Top Employers Institute, a recognized authority on identifying excellence in people practices and workplace culture.
Being certified as a Top Employer showcases Alcon Canada’s c...
Themefolio
Profiler
Peergroup
© BusinessWire
20.06.2025
ALC
LISTED
NYSE
Alcon Introduces Clareon PanOptix Pro in Canada, Delivering the Lowest Light Scatter of any Trifocal IOL
News Preview
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of Clareon® PanOptix® Pro intraocular lens (IOL) for cataract patients in Canada. PanOptix Pro leverages proprietary ENLIGHTEN® NXT Optical technology which delivers the lowest light scatter and highest reported light util...
Themefolio
Profiler
Peergroup
© BusinessWire
28.05.2025
ALC
LISTED
NYSE
Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease
News Preview
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S. Food and Drug Administration (FDA) has approved TRYPTYR® (acoltremon ophthalmic solution) 0.003%, formerly known as AR-15512, for the treatment of signs and symptoms of Dry Eye Disease (DED).3 TRYPTYR is a first-in-class TRPM8...
Themefolio
Profiler
Peergroup
© BusinessWire
13.05.2025
ALC
LISTED
NYSE
Alcon Reports First-Quarter 2025 Results and Launches Transformational Change in Ophthalmic Surgery with Unity VCS
News Preview
Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three months ending March 31, 2025. For the first quarter of 2025, sales were $2.5 billion, flat on a reported basis and up 3% on a constant currency basis1, as compared to the same quarter of the previous year. Alcon reported diluted earnings per share of...
Themefolio
Profiler
Peergroup
© BusinessWire
06.05.2025
ALC
LISTED
NYSE
Alcon Announces Results of 2025 Annual General Meeting
News Preview
Alcon Inc. (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of all proposed resolutions at its 2025 Annual General Meeting (“AGM”).
A total of 332,704,408 shares with a nominal value of CHF 0.04 each, representing an aggregate nominal value of CHF 13,308,176.32, were represen...
Themefolio
Profiler
Peergroup
© BusinessWire
25.04.2025
ALC
LISTED
NYSE
Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* with UNITY VCS and UNITY CS
News Preview
Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced the launch of the UNITY® Vitreoretinal Cataract System (VCS) and UNITY® Cataract System (CS). The new, versatile platform offers two configurations, a combined console (VCS) as well as a standalone cataract system (CS). This platform is designed to de...
Themefolio
Profiler
Peergroup
© BusinessWire
04.04.2025
ALC
LISTED
NYSE
Alcon Publishes Agenda for 2025 Annual General Meeting
News Preview
Alcon (SIX/NYSE: ALC), the global leader in eye care, will hold its Annual General Meeting (AGM) on May 6, 2025.
Alcon is pleased to welcome shareholders to its third in-person AGM since becoming an independent, standalone company. The company looks forward to hearing directly from its shareholders at this open format meeting.
Alcon's Board of D...
Themefolio
Profiler
Peergroup
© BusinessWire
02.04.2025
ALC
LISTED
NYSE
Alcon Expands Leadership in IOL Innovation with Clareon PanOptix Pro, Delivering Best-in-Class Light Utilization and Less Light Scatter
News Preview
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today the introduction of Clareon® PanOptix® Pro intraocular lens (IOL) for cataract patients in the U.S. PanOptix Pro leverages proprietary ENLIGHTEN® NXT Optical technology which delivers the highest reported light utilization of any trifo...
Themefolio
Profiler
Peergroup
© BusinessWire
26.03.2025
ALC
LISTED
NYSE
Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease
News Preview
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced it has acquired a majority interest in Aurion Biotech, Inc., a clinical-stage company developing advanced cell therapies to treat eye diseases.
Aurion will operate as a separate company with full support from Alcon to advance its clin...
Themefolio
Profiler
Peergroup
© BusinessWire
25.03.2025
ALC
LISTED
NYSE
Alcon Announces CE Mark Approval and Commercialization of Clareon Vivity IOL in Europe, Expanding Visual Possibilities
News Preview
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that Vivity®, the most widely implanted9 extended depth of focus (EDOF) intraocular lens (IOL), is now available on Alcon’s most advanced lens material—Clareon®.1 Clareon Vivity® received CE Mark and will commence commercial rollout in...
Themefolio
Profiler
Peergroup
© BusinessWire
24.03.2025
ALC
LISTED
NYSE
Alcon Agrees to Acquire LENSAR, Inc.
News Preview
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and LENSAR, Inc. (NASDAQ: LNSR), a global medical technology company focused on advanced laser solutions for the treatment of cataracts, today announced the companies have entered into a definitive merger agreement through which Alcon intends to acqui...
Themefolio
Profiler
Peergroup
© BusinessWire
13.03.2025
ALC
LISTED
NYSE
Alcon to Host 2025 Capital Markets Day
News Preview
Alcon (SIX/NYSE: ALC), the global leader in eye care, will host its 2025 Capital Markets Day on March 27, 2025, beginning at 8:00 a.m. CT.
A live webcast of the event will be available at the following link: https://investor.alcon.com/news-and-events/events-and-presentations/event-details/2025/Alcons-2025-Capital-Markets-Day-2025-6w85_Spqte/defau...
Themefolio
Profiler
Peergroup
© BusinessWire
27.02.2025
ALC
LISTED
NYSE
Alcon Canada Strengthens its Commitment to Astigmatic Patients with TOTAL30 for Astigmatism Expanded Parameters
News Preview
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the availability of expanded parameters for TOTAL30® for Astigmatism, the first and only monthly replacement Water Gradient toric contact lens,1-3 delivering the same exceptionally comfortable wearing experience,5 now in a –2.75D cylin...
Themefolio
Profiler
Peergroup
© BusinessWire
25.02.2025
ALC
LISTED
NYSE
Alcon Reports Full-Year 2024 Results, with Strong Top-line and Earnings Growth and Record Cash Generation
News Preview
Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three and twelve month periods ending December 31, 2024. For the fourth quarter of 2024, sales were $2.5 billion, an increase of 6% on a reported and constant currency basis1, as compared to the same quarter of the previous year. Alcon reported diluted earn...
Themefolio
Profiler
Peergroup
© BusinessWire
24.02.2025
ALC
LISTED
NYSE
Alcon Announces U.S. Launch of New SYSTANE PRO Preservative-Free, Revolutionizing Dry Eye Relief With Its Longest Lasting Formula Yet
News Preview
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S. launch of SYSTANE® PRO Preservative-Free (PF) as the latest over-the-counter eye drop in the company’s dry eye portfolio. SYSTANE PRO PF is the longest lasting eye drop in the SYSTANE portfolio with a unique triple action, pre...
Themefolio
Profiler
Peergroup
© BusinessWire
19.02.2025
ALC
LISTED
NYSE
Alcon Announces U.S. Launch of Voyager DSLT, First-of-its-Kind Treatment for Glaucoma and Ocular Hypertension
News Preview
Alcon (SIX/NYSE: ALC), the global leader in eye care, dedicated to helping people see brilliantly, announced today the full U.S. commercial availability of Voyager™ DSLT, the first and only Direct Selective Laser Trabeculoplasty device (DSLT). Voyager DSLT is uniquely poised to accelerate the adoption of laser as a first-line therapy, unlocking th...
Themefolio
Profiler
Peergroup
© BusinessWire
31.12.2024
ALC
LISTED
NYSE
Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference
News Preview
Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2025 J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 4:30 p.m. PST.
A live webcast of the conference will be available at investor.alcon.com/news-and-events/events-and-presentations.
About Alcon
Alcon helps people see brilliantly. As the global leader in eye care...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2024
ALC
LISTED
NYSE
Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash Generation
News Preview
Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three and nine month periods ending September 30, 2024. For the third quarter of 2024, sales were $2.4 billion, an increase of 6% on a reported and constant currency basis1, as compared to the same quarter of the previous year. Alcon reported diluted earnin...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2024
ALC
LISTED
NYSE
Alcon Debuts Groundbreaking PRECISION7, a One-Week Replacement Contact Lens to Start and End Every Week Fresh
News Preview
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S. launch of PRECISION7®, the only one-week replacement contact lens with the revolutionary 7-day ACTIV-FLO® System2 that provides 16 hours of outstanding comfort and precise vision, even on day 7.1
While nearly nine out of ten...
Themefolio
Profiler
Peergroup
© BusinessWire
28.10.2024
ALC
LISTED
NYSE
Alcon Singapore Elevates Associate Experience with Inspiring Engagement Programs
News Preview
Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that it has been named one of the ‘Best Employers in Singapore’ for the second consecutive year in addition to its recognition in 2021. This prestigious recognition underscores Alcon’s unwavering commitment to building a strong culture of excellence w...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2024
ALC
LISTED
NYSE
Alcon Innovations on Display at AAO 2024 Demonstrate Efficiency and Performance
News Preview
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, will showcase its latest clinical data and product innovations at the upcoming American Academy of Ophthalmology (AAO) 2024 annual meeting. Ophthalmologists, surgical staff, researchers, and industry leaders can visit Alcon at booth #4008 for hands-on...
Themefolio
Profiler
Peergroup
© BusinessWire
20.08.2024
ALC
LISTED
NYSE
Alcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact Lenses
News Preview
Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three and six month periods ending June 30, 2024. For the second quarter of 2024, sales were $2.5 billion, an increase of 3% on a reported basis and 6% on a constant currency basis1, as compared to the same quarter of the previous year. Alcon reported dilut...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
